This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MedCath Announces Filing Of Certificate Of Dissolution; Delisting From NASDAQ

CHARLOTTE, N.C., Sept. 21, 2012 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH) announced today that the Company has filed a certificate of dissolution with the Delaware Secretary of State (the "Filing").  The Filing was made pursuant to the plan of dissolution the Company's stockholders approved at a special meeting held September 22, 2011.  The Filing became effective as of 5.00 p.m., Eastern Time, September 21, 2012. 

Upon the effectiveness of the Filing, the Company closed its stock transfer books and discontinued recording transfers of its common stock (the "Common Stock"), except for transfers by will, intestate succession or operation of law. From and after the effectiveness of the Filing, the Company's stockholders shall have only such rights and obligations as are provided under the Delaware General Corporation Law for stockholders of a dissolved corporation.   

The Company's Common Stock is listed on the NASDAQ Global Select Market operated by The NASDAQ Stock Market LLC ("NASDAQ").  The Company has notified NASDAQ that the Company has made the Filing, and NASDAQ has advised the Company that NASDAQ will suspend trading of the Common Stock effective prior to market open on Monday, September 24, 2012.  NASDAQ has also advised the Company that it will file with the Securities and Exchange Commission (the "SEC") a Notice of Removal from Listing and/or Registration on Form 25 to delist the Common Stock from NASDAQ.

The Company has filed a Current Report on Form 8-K with the SEC regarding the effect of the Filing upon the rights of the Company's stockholders, the suspension of trading and delisting of the Common Stock by NASDAQ and related matters, including the Company's intent to terminate the periodic reporting requirements the Company is currently subject to under the Securities Exchange Act of 1934, as amended.   A copy of the 8-K report is available on the SEC's website, www.sec.gov, or on our website, www.medcath.com.  

If the Company terminates its obligation to and ceases filing periodic and current reports with the SEC, the Company intends to post periodically on the Company's website a statement of net assets and a statement of changes in net assets and to post from time to time information about any material developments with respect to any significant transactions for disposing of the Company's remaining assets, any significant developments in claims, litigation, investigations and any other future events occurring that could materially impact the timing or amount of liquidating distributions, if any, to be made to the Company's stockholders of record as of the effectiveness of the Filing.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,511.04 -87.16 -0.50%
S&P 500 2,091.41 -6.63 -0.32%
NASDAQ 5,098.9920 -16.39 -0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs